HealthDay on MSN1d
Glucagon-Like Peptide-1 Receptor Agonists May Reduce Alcohol ConsumptionGlucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some ...
News Medical on MSN3d
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumptionThe impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...
A recent study found that glucagon-like peptide-1 receptor (GLP-1) agonists like semaglutide and liraglutide are effective in ...
Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle ...
Popular weight loss drugs have been linked to gastrointestinal, mental health, and vision problems, but the benefits appear ...
News Medical on MSN4d
Exenatide, a GLP-1 analog, by IV during cardiac surgery did not reduce organ injury or deathA large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...
GLP-1 RAs to assist with weight loss have exploded in popularity. Researchers are working to identify which patients will ...
5don MSN
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
Apollo Therapeutics Group Ltd. and Sunshine Lake Pharma Co. Ltd. inked a potential $938 million licensing deal for APL-18881 (HEC-88473), Sunshine’s dual fibroblast growth factor 21 ...
Inno Supps’ Trim Biome™ GLP-1 is designed to support the body’s natural production of GLP-1 through a unique blend of ...
At ObesityWeek 2024, researchers presented the latest data on treatment regimens for chronic weight management, including GLP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback